Guillaume Germain
Montreal
Education
M.Sc. and B.Sc., economics, University of Quebec at Montreal
Summary of Experience
Mr. Germain specializes in health economics and outcomes research (HEOR). He has extensive experience in retrospective database/claims analyses; clinical efficacy, safety profile, treatment patterns, and medication compliance studies; and biostatistics, epidemiology, and health outcomes research with advanced statistical methods, such as survival analysis, general estimating equations, and nonparametric testing. Mr. Germain has conducted research on a broad range of diseases and conditions, including asthma, chronic obstructive pulmonary disease, bipolar disorder, major depressive disorder, atrial fibrillation, venous thromboembolism, cancer, schizophrenia, and hepatitis C. His research has been presented at international conferences including those of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), the Academy of Managed Care Pharmacy (AMCP), the American Heart Association (AHA), and the American Association for the Study of Liver Diseases (AASLD). Mr. Germain’s research and analyses have been published in peer-reviewed journals including The Oncologist, the Journal of Asthma, the Journal of Chronic Obstructive Pulmonary Disease, Clinical Therapeutics, and the Journal of Medical Economics.
Selected Publishing
-
Real-World Healthcare Resource Utilization in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab and Nivolumab in the USA
Targeted Oncology, 2021
2021Laliberté F, Raut M, Yang X, Germain G, Nahar A, Desai KD, MacKnight SD, Sen SS, Duh MS
-
Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities
International Journal of Chronic Obstructive Pulmonary Disease, 2021
2021Kalhan R, Slade D, Ray R, Moretz C, Germain G, Laliberté F, Shen Q, Duh MS, MacKnight SD, Hahn B
-
Real-World Characteristics, Treatment Patterns, Health Care Resource Use, and Costs of Patients with Diffuse Large B-Cell Lymphoma in the U.S.
The Oncologist, 2021
2021Yang X, Laliberté F, Germain G, Raut M, Duh MS, Sen SS, Lejeune D, Desai K, Armand P
-
Real-world impact of antiepileptic drug combinations with versus without perampanel on healthcare resource utilization in patients with epilepsy in the United States
Epilepsy & Behavior, 2021
2021Laliberté F, Duh MS, Barghout V, Germain G, Frech F, Plauschinat C, Lejeune D, Malhotra M, Faught E
-
Cancer associated thrombosis and mortality in patients with cancer stratified by khorana score risk levels
Cancer Medicine, 2020
2020Khorana AA, Kuderer NM, McCrae K, Milentijevic D, Germain G, Laliberté F, MacKnight SD, Lefebvre P, Lyman GH, Streiff MB